109 related articles for article (PubMed ID: 11585747)
1. p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models.
Wen Y; Yan DH; Wang B; Spohn B; Ding Y; Shao R; Zou Y; Xie K; Hung MC
Cancer Res; 2001 Oct; 61(19):7142-7. PubMed ID: 11585747
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antitumor activity by probasin promoter-directed p202 expression.
Wen Y; Giri D; Yan DH; Spohn B; Zinner RG; Xia W; Thompson TC; Matusik RJ; Hung MC
Mol Carcinog; 2003 Jul; 37(3):130-7. PubMed ID: 12884364
[TBL] [Abstract][Full Text] [Related]
3. Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer.
Ding Y; Wen Y; Spohn B; Wang L; Xia W; Kwong KY; Shao R; Li Z; Hortobagyi GN; Hung MC; Yan DH
Clin Cancer Res; 2002 Oct; 8(10):3290-7. PubMed ID: 12374701
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma (Rb) protein upregulates expression of the Ifi202 gene encoding an interferon-inducible negative regulator of cell growth.
Xin H; Pramanik R; Choubey D
Oncogene; 2003 Jul; 22(31):4775-85. PubMed ID: 12894219
[TBL] [Abstract][Full Text] [Related]
5. p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein.
Xin H; D'Souza S; Fang L; Lengyel P; Choubey D
Oncogene; 2001 Oct; 20(47):6828-39. PubMed ID: 11687962
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells.
Wen Y; Yan DH; Spohn B; Deng J; Lin SY; Hung MC
Cancer Res; 2000 Jan; 60(1):42-6. PubMed ID: 10646849
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of the interferon-inducible protein p202 in NIH 3T3 cells affects cell cycle progression.
Lembo D; Angeretti A; Benefazio S; Hertel L; Gariglio M; Novelli F; Landolfo S
J Biol Regul Homeost Agents; 1995; 9(2):42-6. PubMed ID: 9127631
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of E2F-4/DP-1-stimulated transcription by p202.
Choubey D; Gutterman JU
Oncogene; 1997 Jul; 15(3):291-301. PubMed ID: 9233764
[TBL] [Abstract][Full Text] [Related]
9. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202.
Yan DH; Wen Y; Spohn B; Choubey D; Gutterman JU; Hung MC
Oncogene; 1999 Jan; 18(3):807-11. PubMed ID: 9989832
[TBL] [Abstract][Full Text] [Related]
10. p202 prevents apoptosis in murine AKR-2B fibroblasts.
Koul D; Lapushin R; Xu HJ; Mills GB; Gutterman JU; Choubey D
Biochem Biophys Res Commun; 1998 Jun; 247(2):379-82. PubMed ID: 9642135
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
12. P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells.
Yan DH; Abramian A; Li Z; Ding Y; Wen Y; Liu TJ; Hunt K
Biochem Biophys Res Commun; 2003 Mar; 303(1):219-22. PubMed ID: 12646190
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of E2F-mediated transcription by p202.
Choubey D; Li SJ; Datta B; Gutterman JU; Lengyel P
EMBO J; 1996 Oct; 15(20):5668-78. PubMed ID: 8896460
[TBL] [Abstract][Full Text] [Related]
14. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
Miyake K; Shimada M; Nishioka M; Sugimoto K; Batmunkh E; Uto Y; Nagasawa H; Hori H
Cancer Lett; 2008 Dec; 272(2):325-35. PubMed ID: 18762366
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.
Inoue M; Sawada T; Uchima Y; Kimura K; Nishihara T; Tanaka H; Yashiro M; Yamada N; Ohira M; Hirakawa K
Oncol Rep; 2005 Dec; 14(6):1445-51. PubMed ID: 16273237
[TBL] [Abstract][Full Text] [Related]
16. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.
Datta B; Li B; Choubey D; Nallur G; Lengyel P
J Biol Chem; 1996 Nov; 271(44):27544-55. PubMed ID: 8910340
[TBL] [Abstract][Full Text] [Related]
17. p202 levels are negatively regulated by serum growth factors.
Geng Y; D'Souza S; Xin H; Walter S; Choubey D
Cell Growth Differ; 2000 Sep; 11(9):475-83. PubMed ID: 11007452
[TBL] [Abstract][Full Text] [Related]
18. RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo.
Chen Y; Xie D; Yin Li W; Man Cheung C; Yao H; Chan CY; Chan CY; Xu FP; Liu YH; Sung JJ; Kung HF
Cancer Lett; 2010 Nov; 297(1):109-16. PubMed ID: 20684863
[TBL] [Abstract][Full Text] [Related]
19. Binding of an interferon-inducible protein (p202) to the retinoblastoma protein.
Choubey D; Lengyel P
J Biol Chem; 1995 Mar; 270(11):6134-40. PubMed ID: 7890747
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells.
Xiong HQ; Abbruzzese JL; Lin E; Wang L; Zheng L; Xie K
Int J Cancer; 2004 Jan; 108(2):181-8. PubMed ID: 14639600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
